Skip to main content
. Author manuscript; available in PMC: 2021 Feb 19.
Published in final edited form as: ACS Infect Dis. 2020 May 14;6(7):1635–1642. doi: 10.1021/acsinfecdis.0c00010

Figure 1.

Figure 1.

(A) Adherence to Tenofovir disoproxil fumarate can be determined from concentrations of TFV (in plasma, half-life ~15 h) and/or TFV-DP (in red blood cells, half-life ~17 days). TFV-DP is cleared more slowly, so the concentration is better correlated with the long-term average dosing rate. (B) Tenofovir conjugates used in this study.